Krsnaa Diagnostics Ltd

AI
Krsnaa Diagnost. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Krsnaa Diagnostics Ltd

₹ 533 0.00%
16 Oct - close price
krsnaadiagnostics.com BSE: 543328 NSE: KRSNAA
About

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]

Key Points

Business Profile:[1]
Krsnaa Diagnostics Ltd is one of India’s largest integrated diagnostic service providers with a Pan-India presence in Radiology and Pathology. It has established a presence across 18 states and union territories through partnerships with government hospitals and operates 190 CT and MRI centers, 140 pathology laboratories, 4,000+ patient collection centres, and 1,501 tele-radiology centres as of Q3 FY26.

Website BSE NSE
  • Market Cap ₹ 1,730 Cr.
  • Current Price ₹ 533
  • High / Low ₹ 847 / 502
  • Stock P/E 17.8
  • Book Value ₹ 302
  • Dividend Yield 0.38 %
  • ROCE 12.7 %
  • ROE 10.9 %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Promoter holding is low: 27.1%
  • Company has a low return on equity of 9.02% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE 1000 BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
140 155 158 166 170 186 175 186 193 206 181 193 236
108 124 121 123 128 137 129 133 142 147 135 138 178
Operating Profit 31 32 37 44 43 49 45 53 51 59 46 55 58
OPM % 22% 20% 24% 26% 25% 27% 26% 28% 27% 29% 26% 28% 25%
4 4 4 4 7 5 9 4 4 4 4 32 7
Interest 2 3 4 7 5 6 6 7 6 8 8 12 15
Depreciation 16 19 21 18 21 22 23 22 22 24 23 23 28
Profit before tax 18 13 16 23 23 25 25 29 27 32 20 52 22
Tax % 18% 22% 19% 17% 23% 23% 24% 28% 25% 24% 23% 19% 26%
15 10 13 19 18 20 19 21 21 24 15 42 17
EPS in Rs 4.66 3.34 4.02 5.80 5.55 6.07 6.01 6.40 6.33 7.38 4.70 12.86 5.10
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
39 61 455 487 620 717 773 815
30 42 324 365 475 527 561 597
Operating Profit 9 19 132 122 144 190 212 218
OPM % 23% 31% 29% 25% 23% 27% 27% 27%
3 2 15 19 17 26 43 47
Interest 9 9 18 8 16 25 34 43
Depreciation 6 12 41 54 75 88 90 97
Profit before tax -3 0 87 80 70 103 130 125
Tax % 49% 180% 21% 23% 19% 24% 22%
-5 -0 68 62 57 78 101 97
EPS in Rs -4.78 -0.07 21.78 19.78 17.60 24.04 31.27 30.04
Dividend Payout % 0% 0% 11% 14% 14% 11% 6%
Compounded Sales Growth
10 Years: 35%
5 Years: %
3 Years: 17%
TTM: 10%
Compounded Profit Growth
10 Years: 37%
5 Years: %
3 Years: 18%
TTM: 22%
Stock Price CAGR
10 Years: %
5 Years: -6%
3 Years: -9%
1 Year: -32%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 9%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5 5 16 16 16 16 16
Reserves 6 6 669 723 794 867 964
131 102 41 32 160 204 534
44 80 150 137 201 192 304
Total Liabilities 186 192 875 908 1,170 1,278 1,819
74 131 386 471 647 670 656
CWIP 20 6 28 25 10 3 208
Investments 1 1 0 0 0 32 57
91 55 461 412 513 573 897
Total Assets 186 192 875 908 1,170 1,278 1,819

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-23 64 128 76 24 87 143
-47 -54 -241 -109 -129 -100 -396
105 -41 176 -33 84 14 279
Net Cash Flow 36 -31 64 -66 -20 1 26
Free Cash Flow -69 10 -3 -58 -169 -24 -72
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -254% 344% 103% 73% 30% 56% 81%

Ratios

Consolidated / View Standalone

Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 79 84 46 55 104 141 140
Inventory Days 21 24
Days Payable 76 100
Cash Conversion Cycle 24 8 46 55 104 141 140
Working Capital Days -69 -113 -23 11 -21 21 48
ROCE % 7% 12% 10% 12% 13%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Patients Served
million patients

Log in to view insights

Please log in to see hidden values.

Login
Tests Performed
million tests
CT/MRI Centres (Radiology)
count
Pathology Labs (Processing + Reference)
count
Patient Collection Centres
count
NABH Accredited Radiology Centres
count
NABL Accredited Pathology Labs
count
Retail Touch Points
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
27.03% 27.03% 27.17% 27.17% 27.24% 27.24% 27.11% 27.11% 27.11% 27.11% 27.11% 27.11%
3.44% 3.34% 3.33% 3.63% 4.04% 3.55% 3.40% 3.66% 4.17% 3.91% 4.28% 3.84%
16.59% 15.37% 15.26% 15.86% 14.46% 14.26% 14.24% 14.96% 13.85% 13.89% 14.51% 14.50%
52.94% 54.27% 54.23% 53.34% 54.27% 54.94% 55.25% 54.27% 54.86% 55.09% 54.08% 54.55%
No. of Shareholders 57,23256,45855,91453,51952,79953,55954,26252,11752,38053,02253,62550,671

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls